NCT05075863 is a NA clinical trial of Letrozole in Polycystic Ovary Syndrome, sponsored by Nishtar Medical University.

Who is sponsoring NCT05075863?

NCT05075863 is sponsored by Nishtar Medical University.

What drugs are being tested in NCT05075863?

Interventions in NCT05075863: Letrozole.

What condition does NCT05075863 study?

NCT05075863 studies Polycystic Ovary Syndrome.

Is NCT05075863 still recruiting?

NCT05075863 is currently completed. Last updated 14 October 2021.

Last reviewed 2021-10-14 · How we verify

NCT05075863

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Letrozole Versus Clomiphene Citrate on Ovulation Induction in Patients With Polycystic Ovarian Syndrome

Completed NA Last updated 14 October 2021

What this trial tests

NA trial testing Letrozole in Polycystic Ovary Syndrome in 78 participants. Completed in 30 June 2021.

Timeline

1 January 2021

Primary endpoint
30 June 2021

30 June 2021

Quick facts

Lead sponsor	Nishtar Medical University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	78
Start date	1 January 2021
Primary completion	30 June 2021
Estimated completion	30 June 2021
Sites	1 location across Pakistan

Drugs / interventions tested

Letrozole — full drug profile →

Conditions studied

Polycystic Ovary Syndrome — all drugs for Polycystic Ovary Syndrome →

Sponsor

Nishtar Medical University

Who can join

Adults 18 to 30, female only, with Polycystic Ovary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We aimed this study to determine and compare frequency of induction of ovulation in women with polycystic ovarian syndrome treated with Letrozole versus clomiphene citrate as published literature shows variations.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy of letrozole versus clomiphene citrate on ovulation induction in patients with polycystic ovarian syndrome.
Khakwani M, Parveen R, Yousaf S, Tareen AU. · · 2022 · cited 3× · PMID 35799761 · DOI 10.12669/pjms.38.5.5565

Verify or expand the search:

Other trials of Letrozole

Trials testing the same drug.

NCT07391774 — Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribocic · Phase 3 · not yet recruiting
NCT07570966 — Study of ERW316 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and · Phase 1, PHASE2 · not yet recruiting
NCT07492641 — BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer · Phase 3 · not yet recruiting
NCT06905301 — Implementation Study to Describe and Compare Retention Rate and Adherence to Adjuvant Therapy With Ribociclib With and W · recruiting
NCT07288359 — Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and · Phase 1, PHASE2 · recruiting

Other recruiting trials for Polycystic Ovary Syndrome

Currently open trials in the same condition.

NCT07591246 — Efficay of Physical Activity Program in PCOS Females With Fatty Pancrease and Thyroid Hypofunction · NA · recruiting
NCT07446985 — Is There a Benefit From Addition of Physical Exercise to Diet Restriction/Limitation in PCOS Women With Asthma? · NA · recruiting
NCT07385716 — Evaluation of the Effect of Time-Restricted Feeding and Mediterranean Diet Model in Women With Polycystic Ovary Syndrome · NA · recruiting
NCT07366944 — PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes · NA · recruiting
NCT07289399 — Is There a Benefit From Addition of Treadmill Walking to Diet Restriction in Psoriasis Women With PCOS? · NA · recruiting

Other Nishtar Medical University trials

Trials by the same sponsor.

NCT07208799 — Comparison of Submucosal Dexamethasone and Methylprednisolone in Postoperative Sequelae of Parasymphsis Fractures · Phase 2 · recruiting
NCT07537842 — Comparison of Finnish and Viennese Techniques for Perineal Protection in Women During the Second Stage of Labor · NA · completed
NCT07288801 — Vitamin D for Preventing Recurrent Preeclampsia in Pregnant Women · Phase 4 · recruiting
NCT07466342 — Vitamin E Plus Mefenamic Acid Versus Mefenamic Acid Alone for Treating Primary Dysmenorrhea in Women · Phase 4 · completed
NCT07503184 — Intravenous Dexamethasone for Inducing Labor in Women With Term Pregnancy and Pre-Labour Rupture of Membranes · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05075863 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nishtar Medical University
Last refreshed: 14 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05075863.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing